Alloy M4 Face Cream Alternatives: 6 Direct Options, Plus the No-Estriol Route
Before switching from Alloy M4
Compare the real first charge, disclosed strength, amount, refill terms, and compounded status. If a face-cream alternative is not the right category for your symptoms or history, use the care-path guidance instead of a routine checkout.
The closest of the Alloy M4 face cream alternatives is Midi Estriol+ at $149 for 90 mL, with 0.3% estriol disclosed. Wisp has the lowest published 90-day total at $99 with the consult included. Musely has the smallest starting refill charge at $72 for an estimated two months. Alloy's M4 Body Treatment has no direct substitute we could verify.
Where our money comes from, before you read a word: links to Winona and Wisp on this page may earn us a commission at no extra cost to you. We earn nothing from Alloy, Midi, Musely, Evernow, or QuickMD. Two of the three options named in the first answer do not pay us. We'd rather you know that now than find out later. Read our affiliate disclosure.
Best for / not for you if
Switch to Midi if you want every named active disclosed with its concentration and roughly twice the listed product amount for nearly the same price as Alloy.
Switch to Wisp if the lowest published 90-day total matters most and you accept that Wisp does not publish the estriol strength or container amount on its product page.
Switch to Musely if you want a published 0.3% estriol formula with vitamin C and hyaluronic acid, and a smaller two-month refill charge. Your initial known charge is $92, not $72, because Musely adds a $20 doctor-visit fee.
Switch to Winona if you and your clinician want estriol and tretinoin in one compounded cream. Get the concentration of both actives in writing first; Winona does not publish either one.
Stay with Alloy if you use M4 Body Treatment, or if being the only face-cream seller in this comparison with a finished-formula study is worth the premium to you. That's a real thing to value. We'll show you what the study found, including the parts the headline percentages leave out.
Do not route this through a routine online skincare intake if you are pregnant or trying to conceive, have unexplained vaginal bleeding, have a personal history of an estrogen-sensitive cancer, take tamoxifen or an aromatase inhibitor, or have active facial disease that needs diagnosis. Those are clinician-first situations, not checkout questions.
Which Alloy M4 face cream alternative is best at a glance?
Midi is the closest disclosed match; Wisp is the cheapest complete 90-day package; Musely has the smallest refill charge; Winona is the only combined estriol-tretinoin cream; Evernow is the clearest on compounded status; QuickMD is the no-membership option. None is FDA-approved, and several hide strength or volume.
| Option | Published cash price | Published amount | Published formula strength | What the first known charge includes | Editorial fit |
|---|---|---|---|---|---|
| Alloy M4 Face Cream Rx | $150 / 3 months | 45 g | 0.3% estriol in Alloy's study report; not shown on the product page | Product, clinician access, delivery | Finished-formula study; highest transparent unit cost |
| Midi Estriol+ Face Cream | $149 / 90 days | 90 mL | 0.3% estriol, 0.3% DMAE, 0.5% hyaluronic acid | Product and required clinician review; no separate visit fee shown | Closest disclosed formula-and-quantity alternative |
| Wisp Estriol Face Cream | $99 / 90 days | Not published | Not published | Product, online consult, delivery | Lowest published 90-day total; strength and amount not published |
| Musely Aging Repair Cream | $72 / estimated 2 months | Not published | 0.3% estriol, 1% vitamin C, 0.5% hyaluronic acid, aloe | Medication; add $20 for the initial doctor visit | Published formula; smaller refill charge; first known charge $92 |
| Winona Estriol Face Cream with Tretinoin | $150 / 3 months | Not published | Estriol + tretinoin; neither concentration published | Product, doctor access, standard shipping | One-tube retinoid route; concentrations must be confirmed |
| Evernow Facial Estriol Cream | Product price not published | Not published | 0.25% estriol, aloe, vitamin E | Care membership is separate from medication | Strong regulatory disclosure; total cost cannot be calculated publicly |
| QuickMD Estriol Face Cream | $59 / 30 days | Not published | Not published | Medication only; add a $79 doctor visit | No-membership route; initial known cost is $138 if prescribed |
Prices are the sellers' own published cash prices, checked 11 August 2026. Cost comparisons below use the published package amount. Grams and millilitres are not interchangeable measurements for a cream, so Alloy-to-Midi unit comparisons are approximate rather than laboratory-equivalent.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
What are the best Alloy M4 face cream alternatives?
The six direct telehealth alternatives we could verify are Midi, Wisp, Musely, Winona, Evernow, and QuickMD. Midi is the closest disclosed match; Wisp is the lowest published 90-day total; Musely publishes the strongest ingredient detail after Midi; and Winona is the only one here combining estriol with tretinoin. None is a generic M4.
Here's the thing most lists miss. “Alternative” isn't one question. It's two.
Question one: which M4 product are you replacing? Alloy sells four separate prescription products under the M4 name — a face cream, face serum, eye cream, and body treatment — plus multiple bundles. The answer changes by SKU.
Question two: which route do you actually want?
- A lower-cost compounded estriol face cream: Midi, Wisp, Musely, Evernow, or QuickMD.
- Estriol plus a prescription retinoid in one compounded formula: Winona.
- A same-brand texture change: Alloy M4 Face Serum.
- A finished prescription tretinoin product with an FDA-approved photoaging indication: a clinician-and-pharmacy route, not an estriol substitute.
- No prescription and no estriol: an over-the-counter cosmetic route.
A cheaper estriol cream and an FDA-approved tretinoin product are not the same decision. Mixing them up is how people end up with a routine they did not mean to buy, irritation they did not plan for, or a product that cannot answer the goal that sent them searching.
Work through both questions in order and the answer gets simple fast.
Which Alloy M4 product are you actually replacing?
Alloy has four prescription M4 skincare SKUs, and only the face cream has a crowded field of direct substitutes. The eye cream has one emerging estriol competitor. The serum has no direct estriol-plus-peptide match we could verify. The body treatment is 0.2% estriol with peptides, and we found no direct competing prescription product with that same body-use concept.
We built the matrix below by checking each current M4 SKU against the active telehealth alternatives, not by treating “M4” as one bottle.
| M4 product | Current Alloy price | Published amount | Concentration Alloy publishes | Current substitution result |
|---|---|---|---|---|
| M4 Face Cream Rx | $150 / 3 months | 45 g | 0.3% in the 2024 study report; not on the sales page | Six direct telehealth alternatives in the current check |
| M4 Face Serum Rx | $159 / 3 months | 45 g | Not published | No direct estriol-plus-peptide serum match found |
| M4 Eye Cream Rx | $90 / 3 months | Conflicting: 15 g on some Alloy pages, 30 g on others | 1% estriol | Midi now sells an Estriol+ Eye Cream; formula and supply differ |
| M4 Body Treatment Rx | $195 / 3 months | Not published | 0.2% estriol plus peptides | No direct competitor found in the current primary-source check |
The eye cream is not the face cream in a smaller bottle
This is the finding we'd want if we were the one paying.
Alloy's current eye-cream page publishes 1% estriol. The 12-week M4 face-cream study behind the familiar face-cream marketing numbers tested 0.3% estriol on the face and neck. The eye cream was not part of that trial.
| Question | M4 Face Cream Rx | M4 Eye Cream Rx |
|---|---|---|
| Estriol concentration | 0.3% in the study report | 1% on Alloy's product page |
| Intended area | Face and neck | Eye area |
| Included in the 2024 90-person M4 report? | Yes | No |
| Separate public study report located? | 34-page report is public | Alloy cites a 2025 study; full report not located publicly |
Alloy's eye-cream page gives one useful study-summary detail: the cited 2025 study enrolled 34 participants and used instrumental measures, expert grading, and self-assessment over 12 weeks. What remains missing is the report itself. We found the summary, not the data tables, protocol, exclusions, adverse-event detail, or full analysis.
We're not saying the eye cream is unsafe or untested. We're saying the most concentrated M4 product is supported publicly by a study summary, while the complete face-cream report is available for anyone to inspect. Those are different evidence packages.
If you're buying the eye cream, ask this in the portal:
“Please confirm the estriol concentration and the exact gram amount on my order, and send the full clinical study report referenced on the M4 Eye Cream page if it is available to patients.”
Alloy's own pages conflict on whether the eye cream is 15 g or 30 g
The conflict was still live in our August 2026 check. Some official Alloy pages list 15 g; others list 30 g. At the same $90 price, that is the difference between $6.00/g and $3.00/g.
Do not average the two. Do not guess. Confirm the amount at checkout and keep a screenshot. The dispensing label and shipped container beat the bundle page.
Grams and millilitres are close enough for a shopping screen, not for pretending they're identical
Alloy lists the face cream as 45 g. Its study describes a 45 mL dispenser. Midi lists 90 mL. Density can differ by base, so $3.33/g versus $1.66/mL is an approximate unit comparison, not an exact mass-to-volume conversion.
That limitation does not erase the practical difference: Midi publishes twice the listed package quantity for one dollar less. It does mean we will not call the products “identical” or claim a laboratory-precise 50% saving.
Map the care route before you cancel the product. Use Find My HRT Path to see whether your situation belongs with an online provider, a clinician-first route, or a non-hormonal option. The tool takes about 90 seconds, needs no email, and stores nothing.
Is there a cheaper alternative to Alloy M4 cream?
Yes. Wisp has the lowest published 90-day total at $99 with the consult included. Midi gives the most disclosed product for the money at $149 for 90 mL, versus Alloy's $150 for 45 g. Musely starts at a $72 two-month medication charge, but the first known charge is $92 after its $20 doctor fee.
Package prices hide more than they reveal in this category. Some sellers publish supply length but not container amount. Some publish a low medication price but bill the required doctor separately. Some require a membership before showing the drug price.
What actually lands on your card first
| Option | Published medication/package price | Required known add-on at entry | First known charge | Supply represented | What still cannot be calculated |
|---|---|---|---|---|---|
| Alloy M4 Face Cream | $150 | $0 separate clinician fee shown | $150 | 3 months / 45 g | Exact density; state eligibility until intake |
| Midi Estriol+ Face Cream | $149 | $0 separate fee shown | $149 | 90 days / 90 mL | Checkout taxes, if any; individual approval |
| Wisp Estriol Face Cream | $99 | Consult included | $99 | 90 days | Container amount and strength |
| Musely Aging Repair Cream | $72 | $20 initial doctor visit | $92 | Estimated 2 months | Container amount; exact individualized formula until prescribed |
| Winona Estriol + Tretinoin | $150 | Doctor access and standard shipping included | $150 | 3 months | Container amount and both concentrations |
| Evernow Facial Estriol Cream | Not published | Membership is separate | Cannot be calculated publicly | Not published | Medication price, amount, total first charge |
| QuickMD Estriol Face Cream | $59 | $79 doctor visit | $138 if prescribed | 30 days | Strength, amount, and refill-visit cadence |
Show your work
- Alloy: $150 ÷ 45 g = $3.33 per gram.
- Midi: $149 ÷ 90 mL = $1.66 per mL.
- Wisp: $99 ÷ 3 months = $33.00 per represented month.
- Musely: $72 ÷ 2 estimated months = $36.00 per represented month, plus the $20 initial doctor fee.
- QuickMD: $59 medication + $79 required visit = $138 initial known cost if a clinician prescribes it. The medication page does not establish how often another visit will be required.
The cheapest claim changes depending on the denominator
Lowest 90-day package total: Wisp at $99.
Lowest disclosed unit price: Midi at $1.66/mL, compared with Alloy at $3.33/g.
Smallest recurring invoice: Musely at $72 for an estimated two-month refill.
Lowest medication-only sticker: QuickMD at $59 for 30 days — but that number excludes the $79 doctor visit, so it is not the lowest all-in entry price.
This is why “starting at” math is banned from our comparison. A medication-only price is not your first charge when a required visit sits beside it.
About Wisp, which now has the cleanest price and one of the biggest information gaps
Wisp publishes $99 for a 90-day supply, says the online consult is included, and advertises free delivery and availability in all 50 states. That is the lowest complete 90-day price we could verify.
Here's what you give up: Wisp's current product page does not publish the estriol concentration or the container amount. We found third-party pages assigning a concentration, but Wisp did not confirm it on the primary sales page, so it is not used in this comparison.
You are buying on total price and convenience, not on formula transparency.
If $99 all-in for 90 days is the decision you needed resolved, check Wisp's current eligibility and terms →
Commissioned link. Confirm the strength and amount before the prescription is filled.
Musely's two similar-sounding creams are different products
Musely sells The Aging Repair Cream, a compounded estriol formula, and The Anti-Aging Cream, a tretinoin formula. The names are close enough to create a real checkout mistake.
For this comparison, the relevant product is The Aging Repair Cream. Musely publishes a standard formula of 0.3% estriol, 1% vitamin C, 0.5% hyaluronic acid, and aloe. It also states that a prescription is not guaranteed and that a clinician can alter or omit ingredients based on the medical review.
That means the page formula is the standard offered formula, not a promise that your dispensing label will contain every listed ingredient at that exact strength. Read the label when it arrives.
Where are these alternatives available, and what does the price include?
Midi and Wisp publish nationwide availability. Evernow says it serves all 50 states and Washington, DC. Winona currently lists 37 states plus Puerto Rico. Alloy, Musely, and QuickMD require a state-specific eligibility check rather than publishing a complete product-level list we could rely on. None advertises a routine lab package for this skincare prescription.
This is a face-cream comparison, not a systemic HRT-program comparison. A required clinician review still applies, but a routine blood-lab bundle is not advertised as part of any product price below.
| Provider | Published availability we could verify | Clinician step | Routine lab package advertised? | Price inclusion that matters | Cancellation detail visible before purchase |
|---|---|---|---|---|---|
| Alloy | State eligibility confirmed through intake; not all services are available in every state | Medical-history review; prescription required | No | Unlimited clinician messaging/access and delivery included | Detailed terms: 7-day membership cutoff; 5-business-day shipment cutoff |
| Midi Custom Rx | All 50 states | Asynchronous clinician review; prescription required | No | No separate visit fee shown on the $149 product path | Reorder/refill terms should be confirmed at checkout |
| Wisp | All 50 states | Online consult; prescription required | No | Consult and delivery included in $99 | Product page does not show a complete cutoff; confirm before enrolling |
| Musely | Confirm during address and doctor matching | Online doctor visit; prescription not guaranteed | No | $20 initial doctor fee is separate | Auto-refill; confirm the next charge date and cancellation cutoff in the app |
| Winona | 37 states plus Puerto Rico on its current availability page | Doctor review; prescription required | No | Doctor access and standard shipping included | Product page says manage or cancel any time; no precise shipment cutoff shown there |
| Evernow | All 50 states and Washington, DC | Care membership and clinician review | No | Membership and medication are separate | Membership renewal terms apply; medication total is not public |
| QuickMD | Confirm the product in your state during booking | $79 doctor visit; prescription not guaranteed | No | $59 is medication only; free 2-day shipping advertised | No membership; confirm refill and repeat-visit requirements |
Winona's current service area is not “all 50 states”
Winona's current page lists Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, and Wyoming, plus Puerto Rico.
That is 37 states plus Puerto Rico, not nationwide availability. Because licensing changes, check the current list before you build a decision around Winona.
Insurance, HSA/FSA, and “covered” are three different claims
These face creams are usually presented as cash-pay compounded prescriptions. A provider may accept an HSA/FSA card or give you a receipt without guaranteeing that your plan considers the expense eligible. A telehealth visit may be covered while the compounded cream is not. A membership may be self-pay even when the provider offers insurance for other kinds of care.
The useful checkout question is not “Do you take insurance?” It is:
“What will my card be charged today for the clinician review, medication, shipping, and membership, and which parts—if any—will you submit to insurance rather than asking me to seek reimbursement?”
What's actually in each Alloy M4 alternative?
Midi, Musely, and Evernow publish an estriol concentration. Alloy's 0.3% appears in its finished-formula study rather than its current face-cream sales page. Winona names estriol and tretinoin but publishes neither concentration. Wisp and QuickMD name estriol but publish neither the strength nor container amount. That disclosure gap is part of the product, not a footnote.
There's a difference between naming an ingredient and telling you how much is in the medication. Most sellers do the first. Fewer do the second. Even fewer publish the amount of cream, the strength, the exact first charge, and the refill terms on one page.
| Seller | Estriol strength published? | Other named formula components | Amount published? | What the dispensing label still has to confirm |
|---|---|---|---|---|
| Alloy M4 Face Cream | 0.3% in the 2024 study report | Full inactive ingredient list on its site | 45 g | That your prescribed concentration matches the studied formula |
| Midi Estriol+ | 0.3% | 0.3% DMAE, 0.5% hyaluronic acid | 90 mL | Final prescription and pharmacy label |
| Musely Aging Repair | 0.3% standard formula | 1% vitamin C, 0.5% hyaluronic acid, aloe | No | Which listed ingredients and strengths your clinician actually prescribes |
| Evernow Facial Estriol | 0.25% | Aloe vera, vitamin E | No | Final dispensed formula and product price |
| Winona Estriol + Tretinoin | No | Tretinoin is named | No | Both active concentrations |
| Wisp Estriol Face Cream | No | No additional active concentration published | No | Estriol strength and total amount |
| QuickMD Estriol Face Cream | No | No additional active concentration published | No | Estriol strength, amount, and pharmacy formula |
Midi's published DMAE concentration is 0.3%, not 3%
Midi's current formula is 0.3% DMAE, not 3%. The estriol is 0.3% and hyaluronic acid is 0.5%. That correction matters because this is a prescription formula comparison, not a place where a misplaced decimal gets to survive.
“Same concentration” does not mean “same product”
Midi and the formula Alloy studied both disclose 0.3% estriol. That does not make them equivalent. Their bases differ. Midi adds DMAE and hyaluronic acid. The pharmacies differ. The final preparations are compounded and not FDA-approved. Neither product can borrow the other's finished-formula evidence.
The accurate language is same disclosed estriol concentration, not “same medication,” “generic M4,” or “clinically equivalent.”
The label beats every comparison table
A product page can change. A clinician can individualize a compounded prescription. A seller can list a standard formula without guaranteeing that every patient receives every ingredient.
When the package arrives, compare the dispensing label with what you were shown. If the concentration, quantity, pharmacy, or directions differ, stop comparing marketing pages and ask the prescriber or pharmacist to explain the difference.
Is Midi the closest alternative to Alloy M4?
On published numbers, yes. Midi discloses 0.3% estriol—the concentration in Alloy's M4 study—and sells 90 mL for $149. Alloy sells 45 g for $150. Midi is not identical: it adds 0.3% DMAE and 0.5% hyaluronic acid, uses a different base and pharmacy, and has no published trial on its finished formula.
Three things make Midi the closest match we found.
It publishes the amount. Ninety millilitres for $149 versus Alloy's 45 grams for $150. Same price screen. Twice the listed quantity.
It publishes every named active concentration. Estriol 0.3%, DMAE 0.3%, hyaluronic acid 0.5%. That lets you take the formula to your own clinician or dermatologist and ask a precise question.
It publishes a pigmentation warning. Midi tells prospective buyers that estriol may worsen melasma or hyperpigmentation. That is uncomfortable information to put next to an order button. It belongs there.
The thing we have to tell you about Midi
Midi makes an absorption claim that runs past the finished-formula evidence.
Midi's sales copy says topical estriol does not increase circulating hormone levels. Alloy has used similarly absolute language about its product staying local to the skin.
Alloy's own 12-week report supports a narrower sentence: in that selected study population, serum estriol did not change significantly. Serum estradiol rose from 12.92 to 16.60 pg/mL; the report describes the movement as within laboratory error, while its table reports a statistical p-value of 0.037. That mixed presentation is exactly why “never enters the bloodstream” is too absolute.
The study involved women aged 50 to 60, excluded women receiving systemic HRT, used one formula and treatment area, and lasted 12 weeks. It does not establish zero absorption for every woman, every application amount, every duration, or every compounded base.
Midi does not pay us. We're telling you this because the closest disclosed alternative still has marketing language that deserves pressure-testing.
Here's why Midi remains the closest alternative: formula transparency lets another clinician check the work. You cannot have the same conversation about a product whose concentration and amount are both missing.
If the absolute absorption language is your dealbreaker rather than the disclosure, Wisp is cheaper but discloses less. Evernow publishes 0.25% and a cleaner compounded-drug disclosure but does not publish the drug price. There is no option here that gives you every strength, every term, an FDA approval, and a finished-formula trial at the lowest price.
Does that sound like your situation? See Midi's current formula, price, and eligibility →
Non-affiliate editorial link. Confirm the dispensing label before first use.
What about Winona, Musely, Wisp, Evernow, and QuickMD?
Winona is the one-tube estriol-plus-tretinoin route, but publishes neither concentration. Musely publishes a 0.3% standard formula and the smallest refill invoice. Wisp publishes the lowest 90-day all-in price. Evernow publishes 0.25% and the clearest FDA-status disclosure. QuickMD offers a no-membership path but separates the $59 medication from a $79 visit.
Winona — one tube, two unpublished concentrations
Current published price: $150 for a three-month supply. Doctor access and standard shipping are included. Named actives: estriol and tretinoin. Published concentrations: neither one.
This is a genuinely different product, not a cheaper M4. Tretinoin is a prescription retinoid, and specific finished tretinoin products have FDA-approved photoaging indications. That does not make Winona's compounded estriol-tretinoin cream FDA-approved.
Winona does several practical things well. It publishes use instructions, tells users to apply to dry skin, advises a slow start, and provides ongoing doctor messaging. Those details matter with a retinoid.
What we have to flag, about a partner we earn from: Winona's current page calls the compounded cream “clinically proven” and says its active ingredients, including estriol, are FDA-approved. The estriol statement is wrong. FDA says there are no FDA-approved drugs containing estriol. The finished Winona preparation is compounded and not FDA-approved.
Tretinoin does exist in FDA-approved finished products. That fact cannot be transferred to the compounded combination as a whole, and it cannot turn estriol into an FDA-approved ingredient.
Who Winona may fit: someone whose clinician agrees a retinoid belongs in the routine, who values one tube, lives in a currently served jurisdiction, and will get both active concentrations in writing before the pharmacy fills it.
Who should skip it: anyone pregnant or trying to conceive, anyone who cannot tolerate retinoids, anyone with a routine already heavy in irritating actives, or anyone who will not buy without published concentrations.
If one tube for estriol plus a clinician-selected retinoid is the specific route you want, check Winona's current eligibility → and ask for both percentages before the prescription is sent.
Commissioned link. The FDA correction above stands regardless.
Musely — published formula, smaller refill charge, individualized prescription
Current published entry: $72 for an estimated two-month medication supply, plus a $20 initial doctor visit. Standard formula: 0.3% estriol, 1% vitamin C, 0.5% hyaluronic acid, and aloe.
Your first known charge is $92, not $72. The recurring medication invoice is $72, but the represented monthly cost is about $36—higher than Wisp's $33 monthly equivalent.
Musely also publishes something other sellers bury: a prescription is not guaranteed, and a clinician may alter the formula. That means the standard formula is useful for comparison, but the dispensing label is the final answer.
The Aging Repair Cream is not a systemic menopause treatment. It is not the product to choose for hot flashes, night sweats, sleep disruption, vaginal symptoms, or other whole-body menopause concerns.
Wisp — the lowest published 90-day total
Current published price: $99 for a 90-day supply, with the consult included and free delivery. Availability: all 50 states. Published concentration and container amount: neither.
Wisp wins the checkout number and loses the disclosure comparison. That can still be the right trade if the prescribing clinician and pharmacy give you the missing information before fulfillment.
Do not let a low all-in price turn “I don't know the strength” into “the strength probably doesn't matter.” Ask.
Evernow — the clearest compounded-drug disclosure, but no public drug price
Evernow publishes 0.25% estriol with aloe and vitamin E. It also states clearly that the cream is compounded, not FDA-approved, and not evaluated by FDA for safety or effectiveness before marketing.
That is the regulatory sentence every seller in this category should be willing to print.
The catch is price transparency. Evernow publishes care membership prices, but the facial-estriol medication price is not displayed on the public product page. Membership and medication are separate, so the real first charge cannot be calculated before intake.
QuickMD — no membership, but the $59 headline is medication only
QuickMD publishes $59 for a 30-day medication supply with free two-day shipping. It also states that the required doctor visit costs $79, prescriptions are not guaranteed, and the listed medication price excludes the visit.
That makes the first known charge $138 if prescribed, not $59. QuickMD does not publish the estriol strength or container amount on the product page, and the refill/visit cadence should be confirmed before treating the first-month number as an ongoing monthly total.
This route makes the most sense for someone who dislikes memberships and wants a direct visit-plus-medication model—not someone looking only at the largest number in the hero banner.
What if you don't want estriol at all?
Two routes skip estriol. One is a clinician-selected finished tretinoin product with an FDA-approved photoaging indication, such as Renova 0.02% or tretinoin cream USP (emollient) 0.05% under its approved labeling. The other is an over-the-counter cosmetic. Neither is a like-for-like M4 substitute, and neither gets to borrow M4's claims.
The FDA-approved prescription route is product-specific
Renova is not the only finished tretinoin cream with an FDA-approved photoaging indication.
Renova 0.02% is FDA-approved as an adjunctive treatment to mitigate fine facial wrinkles in patients using comprehensive skincare and sun avoidance. Tretinoin cream USP (emollient) 0.05%, historically marketed as Refissa, has an approved adjunctive indication covering fine wrinkling, mottled hyperpigmentation, and tactile roughness under its label.
That does not mean every tretinoin tube, every concentration, every compounded tretinoin formula, or the Winona combination has the same approval. FDA approval belongs to the specific finished drug, strength, formulation, manufacturer application, and labeled use.
The labels are also brutally honest about limits. Renova is not labeled to eliminate wrinkles, repair sun-damaged skin, or reverse photoaging. Both labels require comprehensive skincare and sun avoidance alongside treatment. The 0.05% emollient label reports that many vehicle-treated patients also improved with the skincare program.
Sit with that for a second.
The finished prescription products FDA reviewed are required to state what they cannot do and how much ordinary skincare contributes. Compounded estriol sellers can put a large percentage on the page without the same premarket review.
That is not an argument that every reader should choose tretinoin. Tretinoin can irritate, is not appropriate in pregnancy, and may not fit your skin. It is an argument for comparing regulatory evidence honestly.
The over-the-counter route
Some cosmetics for estrogen-deficient or postmenopausal skin use MEP, methyl estradiolpropanoate, which the manufacturer describes as a non-hormonal estrogen-receptor-active cosmetic ingredient. No prescription. No estriol. No FDA drug approval.
It is a different category with a different evidence package. Do not call it “the same as estrogen without the risk.” It is not estriol, it is not an approved drug, and cosmetic status does not prove clinical equivalence.
The same investigator led the main MEP pilot and Alloy's M4 study
Zoe Diana Draelos, MD, led the 2018 double-blind randomized MEP pilot published in the Journal of Drugs in Dermatology and is the investigator named on Alloy's 2024 M4 report. Both were single-site, vehicle-controlled studies lasting about 12 weeks in postmenopausal women who had not used hormone therapy; both were funded by the company behind the tested product.
We're not suggesting anything improper. Contract research investigators run studies for competing companies. That is the job.
What it tells you is that the two “estrogen signaling for your face” evidence stories are less independent in design and population than two separate marketing pages make them look. In both cases, investigator ratings and participant reports carry substantial weight. That pattern belongs in the decision.
The route we'd be dishonest to leave out
If you have never used daily broad-spectrum sunscreen, a simple moisturizer, or a clinician-selected retinoid, you are considering a $99-to-$150 compounded purchase before testing the foundation built into the FDA-approved tretinoin labels themselves.
That foundation is not a consolation prize. For some women, it is the more sensible first move. We earn nothing from sunscreen or moisturizer.
Want the no-estriol route? Use Find My HRT Path to separate a skin-only question from a broader menopause-care need, then take the result to the clinician you choose. The tool does not prescribe and will flag when online care is not the right starting point.
Does estriol face cream actually work? What Alloy's study says
Alloy's 12-week report randomized 90 postmenopausal women to 0.3% estriol cream, 0.01% estradiol cream, or the vehicle base; 86 completed. Instrument-measured skin hydration rose 26% in the estriol group. The elasticity instrument found no consistent change. Investigator grades favored estriol on several endpoints, while participant ratings did not meaningfully distinguish the three products.
This is the section that decides whether switching costs you anything. So let's be careful and fair.
What Alloy advertises, next to what the report contains
| Alloy marketing statement | What the full report contains |
|---|---|
| “88% improvement in elasticity” | The 88% is an investigator-grade comparison between estriol and vehicle on an ordinal scale. The Cutometer instrument found no consistent change in skin elasticity in any group. |
| “70% improvement in hydration” | The 70% is an investigator-grade comparison against vehicle. Within the estriol arm, the investigator hydration grade changed about 2% from baseline in that table. Separately, the Corneometer found a 26% increase in skin water content, which is the stronger objective hydration result. |
| “Clinically proven” | Alloy commissioned a randomized, double-blind, vehicle-controlled finished-formula report. It is real product-specific evidence, but it is sponsor-funded and we found no peer-reviewed publication of the full M4 study. |
| (not in the headline) | Participant self-assessments were excellent across estriol, estradiol, and vehicle, and did not clearly separate the active creams from the base. |
| (not in the headline) | Transepidermal water loss increased 13% in the estriol group at week 12, with p=0.027. The report states lower values are generally better. No irritation or adverse events were reported during the 12-week study. |
| (not in the headline) | Fine lines, wrinkles, and pore size were not among the statistically significant investigator-grade estriol findings in the report's summary table. |
What holds up best
Hydration held up under an instrument. A 26% Corneometer increase with p=0.001 is the clearest objective positive result in the report. Dryness is a real menopause skin complaint. That result matters.
Elasticity did not hold up under the dedicated instrument. The investigator grade and Cutometer answered the question differently. Alloy advertises the favorable investigator comparison; a complete reading includes both.
The vehicle performed well in participant ratings. A well-formulated cream base can feel good and make skin look better. The study was not designed to tell us how much of the participant experience came from estriol versus the base ingredients.
The water-loss result points the other way. A 13% increase in transepidermal water loss is a barrier-direction signal worth seeing. It is not proof of clinical harm, and the study reported no irritation or adverse events. It does prevent a one-sided “every objective measure improved” story.
The women in the study may not resemble your routine
The trial enrolled women aged 50 to 60, at least one year past menopause, with mild-to-moderate facial photoaging. It excluded women receiving HRT and people using many common skincare or cosmetic treatments.
The report's exclusions included:
- Hormone replacement therapy.
- Topical retinoids, retinol, or other vitamin A derivatives in the prior three months or during the study.
- Systemic retinoids in the prior year.
- Botox, fillers, laser, dermabrasion, microdermabrasion, or chemical peels in the prior six months.
- Other medicated topical products on the treatment area.
- Alpha-hydroxy acids, salicylic acid, or vitamin C on the face shortly before or during the study.
So the tested routine was unusually controlled. If you already use HRT, tretinoin, acids, vitamin C, lasers, injectables, or a complex moisturizer routine, the report does not directly test your combination.
Winona's estriol-plus-tretinoin product is the cleanest example: Alloy's study excluded the very retinoid combination Winona sells.
Serum hormone results do not prove “zero absorption”
The report found no significant change in serum estriol. Estradiol moved from 12.92 to 16.60 pg/mL; the narrative calls the change within laboratory error, while the table reports p=0.037.
The responsible conclusion is not “the cream definitely raises systemic estrogen,” and it is not “none enters the bloodstream.” The responsible conclusion is that this 12-week study did not show a significant estriol increase in its selected population, while its estradiol presentation is internally harder to summarize than the marketing sentence suggests.
The honest bottom line on switching
Here's the part that cuts against the easy affiliate story.
Alloy is the only seller in this direct face-cream comparison that published a controlled study on its own finished formula. Midi, Wisp, Musely, Winona, Evernow, and QuickMD do not publish comparable finished-product trials on the creams in this table.
That is real value. It is also smaller and more mixed than the 88% headline makes it look.
If finished-formula evidence is worth paying for, staying with Alloy is defensible. If the objective hydration result is the only outcome you care about, you can see exactly what supports it. If elasticity or wrinkles are the reason you were about to pay a premium, the full report gives you a reason to slow down.
Can estriol face cream make melasma worse?
Possibly. Pigment-prone readers should not treat this as a routine moisturizer. Alloy's 12-week study found no significant pigmentation increase and showed small melanin decreases. Midi warns that estriol may exacerbate melasma or hyperpigmentation. A peer-reviewed case report has also linked topical estrogen cream with melasma, although one case cannot establish how often it happens.
If you have melasma, chloasma, post-inflammatory hyperpigmentation, dark patches after pregnancy or hormonal contraception, or skin that pigments easily, this is one of the most important sections on the page.
| Source | What it found or warns | What it cannot settle |
|---|---|---|
| Alloy M4 report, 2024 | Imaging showed small melanin decreases rather than an increase during 12 weeks | Longer-term pigment response, summer exposure, or pigment-prone populations |
| Midi product and clinical content | Warns that estriol may worsen melasma/hyperpigmentation and advises care on prone areas | Does not quantify the risk for its finished cream |
| Peer-reviewed case report, 2017 | Reported melasma after topical estrogen cream was applied to the affected skin | One case cannot estimate risk or prove the same outcome for 0.3% facial estriol |
Why a 12-week study may not close the question
Melasma is influenced by hormones, ultraviolet exposure, visible light, genetics, and time. A short trial selected for mild-to-moderate photoaging—not for a history of melasma—can miss a problem that emerges later or in a different population.
That is a limitation of the design, not proof that the risk will happen.
What to ask before you buy
“I have a history of melasma or hormone-linked pigmentation. Does that change whether topical estriol fits me, where I should apply it, and what change should make me stop and contact you?”
Daily broad-spectrum sunscreen is part of every sensible route on this page, including the FDA-approved tretinoin labels. For pigment-prone skin, ask whether tinted sunscreen with visible-light protection belongs in the plan as well.
Not sure whether pigmentation history changes the route? Use Find My HRT Path before you spend anything. It will not diagnose melasma, but it can route a safety-history answer away from a generic online checkout when that is the wrong starting point.
Are Alloy M4 and the alternatives FDA-approved?
No. FDA says there are no FDA-approved drugs containing estriol. Alloy M4, Midi, Wisp, Musely, Winona, Evernow, and QuickMD facial estriol preparations are compounded prescriptions, not FDA-approved finished drugs. FDA does not review compounded drugs for safety, effectiveness, or manufacturing quality before they reach the market.
A few things are worth saying precisely.
Compounded does not automatically mean illegal. Compounding can be lawful when the prescriber, pharmacy or outsourcing facility, prescription, ingredients, and distribution meet applicable federal and state requirements.
Compounded does not automatically mean unsafe. It means the finished product did not go through FDA's premarket approval process. Quality still depends on the compounder, prescription, ingredients, testing, storage, and handling.
“Bioidentical” is not an approval category. A seller can use that word without the finished product being FDA-approved or shown safer than approved hormone therapy.
An approved ingredient elsewhere does not approve this product. Tretinoin exists in FDA-approved finished drugs. That does not approve Winona's compounded estriol-tretinoin cream. Estriol itself has no FDA-approved US drug.
Compounded is not generic. A generic drug is FDA-approved against a reference listed drug. A custom compounded estriol cream is not a generic version of Alloy, because Alloy is not an FDA-approved reference drug and no FDA-approved estriol drug exists.
This section does not choose the winner for you because every direct estriol option shares the same top-line status. The decision moves to the details FDA has not pre-cleared for you: exact formula, amount, pharmacy, clinician review, adverse-reaction plan, price, and refill terms.
For the broader regulatory background, see our guide to prescription estriol face cream online.
Can you use vaginal estrogen cream on your face instead?
Do not improvise that switch unless the clinician who prescribed the vaginal product specifically directs facial use. Vaginal estrogen products may use a different estrogen, concentration, base, dosing device, and labeled treatment site. There is no FDA-approved facial dosing instruction for repurposing vaginal estrogen cream, and this page will not invent one.
This question comes from a completely understandable place. Someone already has an insurance-covered vaginal estrogen prescription, sees a $99-to-$150 face cream, and does the math.
We understand the logic. We're still going to say no to do-it-yourself dosing.
US vaginal creams commonly contain estradiol or conjugated estrogens rather than estriol. Their concentrations, bases, applicators, and approved uses were developed for vaginal tissue and symptoms, not for a facial skincare routine.
What to do instead: message the prescriber and ask whether a face-specific compounded prescription, a finished tretinoin product, or a non-hormonal routine fits your goal.
What we will not tell you: how much vaginal cream to put on your face, how to dilute it, where to apply it, or how often. There is no standardized approved answer, and a website should not make up a hormone dose.
How do you cancel Alloy or get a refund?
Alloy accepts refund requests for physical products within 30 days of receipt, but only for the first shipment of each product. Products are not physically returnable. Membership cancellation is due at least seven days before the current period ends, while a shipment pause or cancellation is due five business days before processing. Damaged or missing shipments have a 14-day replacement window.
If you're switching, these are the numbers that matter this week—not next month.
| Action | Current Alloy rule | Why it matters |
|---|---|---|
| Refund request | Submit within 30 days of receiving the shipment | The clock starts at receipt, not order date |
| Eligible shipment | First shipment of each product only | A second bottle of the same product is not refund-eligible under the published rule |
| Physical return | Products are not returnable | Refund eligibility and physical return are separate questions |
| Cancel membership/subscription | At least 7 days before the current subscription period ends | Stops renewal under the membership rule |
| Cancel or pause a shipment | At least 5 business days before the shipment is scheduled to process | This is the operational cutoff most likely to be missed |
| Damaged or undelivered shipment | Contact within 14 days for replacement | Published remedy is replacement, not refund |
| Prescription transfer | You may request transfer to a pharmacy of your choice | You are not required to leave the prescription at Alloy's partner pharmacy |
Source: Alloy Terms of Use, effective 28 May 2026; rechecked 10 August 2026.
Cancel and refund are two different actions
Cancelling stops a future renewal or shipment. It does not automatically refund a shipment already delivered. If you are within the first-shipment refund window, make the cancellation request and refund request separately, in writing, and keep the timestamps.
Build your two dates before you send the message
Use the dates in your own account, not a generic three-month assumption.
- Refund-request deadline: delivery date + 30 calendar days.
- Shipment-change deadline: scheduled processing date minus 5 business days.
- Membership-cancellation deadline: current period end date minus 7 calendar days.
- Use the earliest relevant deadline as your action date.
- Save the confirmation email or dashboard screenshot.
This is not a promise that every refund request will be granted. It is the cleanest way to avoid missing a published cutoff.
Before you cancel a hormone-related product because the whole care path feels wrong, run Find My HRT Path. It takes about 90 seconds, requires no email, and stores nothing. Cancel the right product for the right reason—not because two different care decisions got tangled together.
What should you ask before switching from Alloy M4?
Get seven commercial facts and five clinical answers before paying: exact active concentrations, amount, first charge, next charge date, cancellation cutoff, dispensing pharmacy, stop-contact instructions, medical-fit review, pigmentation history, interaction with your routine, whether actives should stay separate, and what result will determine whether you continue.
Print this. Take it to checkout. It works on every seller on this page, including Alloy.
Seven questions for the seller
- What exact percentage of every active will be dispensed to me?
- How many grams or millilitres am I getting?
- What will my card be charged today, including clinician, medication, shipping, and membership fees?
- What date will the next charge occur, and for how much?
- What is the last date to cancel before that charge or shipment?
- Which pharmacy will compound and ship my prescription?
- What reaction should make me stop and contact the clinician or pharmacist?
Five questions for the clinician
- Does my cancer, clotting, liver, bleeding, pregnancy, medication, or pigmentation history change whether this route fits?
- Does my skin condition need an in-person exam before a hormone-containing facial product?
- Should estriol and a retinoid be combined, or kept separate so each can be adjusted?
- How does this fit with the retinoid, acids, vitamin C, procedures, or HRT I already use?
- What will we assess in eight to twelve weeks to decide whether the cost is justified?
One rule outranks the whole page: the dispensing label beats the marketing page.
Who should not start an estriol face cream through a routine online intake?
A routine skincare checkout is the wrong starting point when your history needs individualized risk review or your skin needs diagnosis. Pregnancy or attempted conception, unexplained vaginal bleeding, estrogen-sensitive cancer history, tamoxifen or aromatase-inhibitor use, clotting or major liver history, and active facial disease deserve clinician-led evaluation before a compounded estrogen cream.
We'd rather lose you here than have you buy the wrong thing.
Use an in-person clinician or a clinician already managing your history first if:
- You are pregnant, trying to conceive, or breastfeeding.
- You have unexplained vaginal bleeding.
- You have a personal history of breast, uterine, ovarian, or another estrogen-sensitive cancer.
- You take tamoxifen or an aromatase inhibitor.
- You have a history of blood clots, stroke, major arterial disease, or significant liver disease.
- You have active rosacea, eczema, psoriasis, infection, open skin, severe acne, or another condition that needs diagnosis.
- You are already using prescription tretinoin, isotretinoin, strong acids, or a procedure schedule that needs coordination.
- You have melasma or hormone-linked pigmentation and have not discussed it with a clinician.
These are not a universal list of permanent bans. They are reasons a generic online skincare flow should not make the decision alone.
Two disqualifications by goal
If your real problem is hot flashes, night sweats, disrupted sleep, painful sex, recurrent urinary symptoms, or other menopause symptoms, you're in the wrong aisle. A face cream is not systemic menopause treatment and should not delay the care route that addresses those symptoms.
If your goal is ordinary photoaging and you have never used sunscreen consistently or discussed a finished prescription tretinoin product, start with that question. You may still choose estriol later. You should know what the less expensive, better-regulated branch looks like first.
What did The HRT Index verify, and what remains unknown?
We rechecked each seller's public product page, current price, displayed formula, clinician-fee structure, published availability, and Alloy's May 2026 terms on 10–11 August 2026. We also read Alloy's full 34-page face-cream report and FDA labeling for two finished tretinoin products. Missing values stay missing; we do not fill them with forum claims.
The HRT Index Verification Standard means we read every published price, separate FDA-approved from compounded options, verify state availability and insurance where possible, and re-check on a fixed schedule—top providers monthly and the full roster quarterly. We evaluate in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not publish invented per-provider scores.
Provider-stated versus verified in our current check
| Claim | Provider-stated information | What we verified | Decision impact |
|---|---|---|---|
| Alloy face cream price | $150 | Live skincare page showed $150 on 11 Aug 2026 | Use the current $150 price; older figures are stale |
| Alloy face formula strength | Product page does not show it | Finished-formula report tested 0.3% estriol | Use 0.3% only with study context |
| Midi DMAE concentration | 0.3% | Current Midi formula page | Use 0.3%; 3% is incorrect |
| Wisp lowest 90-day total | $99, consult included | Current Wisp product page | Cheapest complete published 90-day package |
| Musely $36/month headline | $72 starting medication supply for about two months | Current sales page plus $20 doctor fee | First known charge is $92; not a $36 first charge |
| Winona “FDA approved” language | Page says estriol and tretinoin are FDA-approved | FDA says no estriol drug is FDA-approved | Finished compounded cream must be labeled not FDA-approved |
| QuickMD $59 headline | $59 for 30-day medication | Same page excludes $79 doctor visit | Initial known cost is $138 if prescribed |
| Alloy eye size | Official pages conflict between 15 g and 30 g | Conflict remained live | Do not calculate one unit price without checkout confirmation |
What we read ourselves
- Every seller's live product page used in the comparison.
- Alloy's 34-page 2024 M4 face-cream report, including design, population, exclusions, instrumental measures, investigator grades, serum data, and adverse-event section.
- Alloy's Terms of Use for refund, cancellation, shipment, replacement, pharmacy, and prescription-transfer terms.
- FDA's current menopause and drug-compounding guidance.
- DailyMed labeling for Renova 0.02% and tretinoin cream USP (emollient) 0.05%.
- Peer-reviewed literature on topical estrogen/MEP and skin aging.
What we could not confirm and are not guessing at
- Winona's estriol concentration.
- Winona's tretinoin concentration.
- Wisp's estriol concentration and container amount.
- QuickMD's estriol concentration and container amount.
- The public medication price for Evernow's facial estriol cream.
- The amount in Alloy's M4 Body Treatment bottle.
- One authoritative Alloy eye-cream amount; official pages publish both 15 g and 30 g.
- A public full report for Alloy's 2025 M4 Eye Cream study.
- A direct prescription estriol-plus-peptide body-treatment alternative.
- Your personal insurance or HSA/FSA eligibility.
- Product eligibility in any state a seller does not explicitly list before intake.
How we reached the recommendations
- Closest disclosed alternative: published estriol concentration, published amount, and comparable supply.
- Lowest 90-day total: medication, required consult, and known mandatory fees included.
- Lowest unit cost: only calculated where amount is published; grams and millilitres remain labeled separately.
- Best formula transparency: every named active has a published concentration.
- No direct substitute: current primary-source market check found no comparable product, and the gap is labeled rather than filled with a cosmetic that does something else.
Found something we got wrong? Tell us. We'd rather fix it than defend it.
Frequently asked questions
Is there a generic version of Alloy M4?
No. Generic drugs are FDA-approved versions of an FDA-approved reference drug. Alloy M4 is a compounded estriol prescription, not an FDA-approved reference product, and FDA says there are no FDA-approved estriol drugs. Other compounded estriol creams are alternatives, not generic M4.
What's the closest dupe for Alloy M4 face cream?
Midi Estriol+ is the closest disclosed alternative we found. It publishes 0.3% estriol—the concentration in Alloy's study—and 90 mL for $149. It is not identical: Midi adds 0.3% DMAE and 0.5% hyaluronic acid, uses a different base and pharmacy, and has no published finished-formula trial comparable to Alloy's report.
Is Midi's estriol cream the same as Alloy M4?
No. They share a disclosed 0.3% estriol concentration in current sources, but they are different compounded preparations with different bases, added ingredients, amounts, pharmacies, and evidence packages. “Same concentration” is accurate. “Same product” is not.
How much estriol is in Alloy M4?
Alloy's 2024 face-cream study tested 0.3% estriol. The current M4 Face Cream sales page does not display that concentration. Alloy's M4 Eye Cream page displays 1% estriol, and the Body Treatment page displays 0.2% estriol.
Which Alloy M4 alternative is cheapest?
Wisp has the lowest complete published 90-day price at $99 with the consult included. Midi has the lowest disclosed unit price at $1.66/mL. Musely has the smallest refill invoice at $72 for an estimated two months, but the first known charge is $92 after the initial doctor fee. QuickMD's $59 medication headline becomes $138 when the required $79 visit is added.
Does Alloy M4 have an eye-cream alternative?
Midi sells an Estriol+ Eye Cream, so Alloy no longer stands alone in prescription estriol eye-area products. The formulas and study packages differ. Alloy's own pages also conflict on whether its eye cream contains 15 g or 30 g, so confirm the amount before comparing cost per gram.
Is there an alternative to M4 Body Treatment?
We found no direct prescription competitor combining estriol and peptides for broad body use. Alloy publishes 0.2% estriol for M4 Body Treatment and calls it the only prescription estriol-plus-peptide body treatment. Our current search did not disprove that claim. A plain body moisturizer or peptide cosmetic is not a direct prescription substitute.
Can I use estriol face cream if I'm already on hormone therapy?
Ask the clinician managing your HRT. Alloy's M4 study excluded women receiving hormone replacement therapy, so that report does not directly answer combined-use questions. Do not use the absence of a serum estriol change in that selected study as permission for every combination.
Will insurance or HSA/FSA cover these creams?
Do not assume it. Most are presented as cash-pay compounded products. A provider may accept an HSA/FSA card or supply a receipt without guaranteeing eligibility. Ask separately what the provider bills to insurance, what you pay today, and whether the compounded medication itself is covered.
Can I get estriol face cream at a regular pharmacy?
A prescription estriol cream must be compounded; it is not an FDA-approved mass-manufactured drug stocked like a standard generic. Some community compounding pharmacies may fill a transferred prescription if they are licensed and able to make the formula. Alloy's terms allow a patient to request transfer to a pharmacy of choice.
Can I use estriol face cream with tretinoin?
Sometimes a clinician intentionally combines them—Winona sells that model—but irritation and routine complexity matter. Alloy's M4 face-cream study excluded topical retinoids, so it does not establish the safety or performance of layering or combining the two. Ask whether to combine, separate, alternate, or avoid them based on your skin and pregnancy status.
What happens if I stop using estriol face cream?
There is no strong finished-product discontinuation dataset for the compounded estriol creams in this comparison. Any cosmetic benefit may fade when treatment stops, but the timing and degree are not established well enough to promise. Do not borrow the discontinuation data from an FDA-approved tretinoin label and pretend it belongs to estriol.
Is compounded the same as FDA-approved?
No. Compounded drugs are prepared for prescriptions under a different legal framework and do not receive FDA premarket review for safety, effectiveness, or quality. Compounding can be lawful and clinically appropriate. It is still not FDA approval.
Does M4 really improve elasticity by 88%?
The 88% figure is an investigator-grade comparison against vehicle, not an 88% machine-measured increase from each participant's baseline. The Cutometer instrument in the same report found no consistent elasticity change in any group. Both results belong in the answer.
Does M4 really improve hydration by 70%?
The 70% is an investigator-grade comparison against vehicle. The strongest objective hydration result is separate: Corneometer-measured skin water content increased 26% in the estriol group. The 2% figure is the within-arm investigator-grade change—not a statement that every woman's hydration rose exactly 2%.
Is Winona's estriol cream FDA-approved because it contains tretinoin?
No. Specific finished tretinoin products are FDA-approved. Estriol is not FDA-approved in any US drug, and Winona's compounded combination is not an FDA-approved finished product. Approval does not transfer from one ingredient in another product.
Are these products available in every state?
Not uniformly. Midi and Wisp publish all-50-state availability; Evernow publishes all 50 states plus Washington, DC; Winona currently lists 37 states plus Puerto Rico. Other sellers require state-specific intake confirmation. Licensing and service areas change, so check again before paying.
Which Alloy M4 alternative should you choose?
Choose Midi for the closest disclosed match, Wisp for the lowest complete 90-day price, Musely for a published multi-active formula and smaller refill invoice, Winona for one-tube estriol plus tretinoin, and a finished tretinoin product if FDA-approved photoaging labeling matters more than estriol.
- “M4 is too expensive.” Choose Wisp for the lowest published 90-day total, or Midi for the clearest amount-and-strength value.
- “I want to know exactly what I'm putting on my face.” Midi publishes every named active concentration; Evernow also publishes its 0.25% estriol strength and a clear compounded-drug disclosure.
- “I want tretinoin in the same tube.” Winona is the verified one-tube route, but get both concentrations in writing and do not confuse the compounded combination with an FDA-approved finished tretinoin product.
- “I like Alloy but hate the cream texture.” M4 Face Serum is a texture change, not a saving. It costs $159 for three months and has no direct estriol-plus-peptide serum match we found.
- “I want an FDA-approved prescription route.” Ask a clinician about a specific finished tretinoin product with a photoaging indication. Do not accept “contains an approved ingredient” as a substitute for finished-product approval.
- “I don't want a hormone on my face.” Choose the no-estriol branch: sunscreen, moisturizer, a clinician-selected retinoid if appropriate, or an over-the-counter cosmetic whose claims you evaluate on its own evidence.
- “I use M4 Body Treatment.” Stay unless your goal can be met by a non-equivalent body-care routine. We found no direct prescription estriol-plus-peptide substitute.
One last honest word. A different product is not automatically a better decision.
Midi gives you more disclosed product for almost the same package price, but it does not bring Alloy's finished-formula study with it. Wisp saves more at checkout but asks you to tolerate missing strength and amount. Winona adds a retinoid that changes both the potential benefit and the irritation conversation. Musely publishes a useful standard formula but can individualize what is actually prescribed.
The useful choice is the one whose formula, price, pharmacy, terms, and evidence you were able to check—not the one with the loudest before-and-after.
You already knew something was off about the price. You were right. Now you know exactly what the verified alternatives cost, where the comparison breaks, and what you would actually give up.
Still not sure which HRT program is right for you? Take our free 90-second matching quiz.
Sources
Alloy and M4
- Alloy M4 Face Cream Rx and current skincare price index — accessed 11 August 2026.
- Alloy M4 Eye Cream Rx — 1% estriol, $90, 3-month supply, 2025 study summary; accessed 11 August 2026.
- Alloy Advanced Essentials, Daily Strength Duo, and Glow & Go pages — official 15 g/30 g eye-cream amount conflict; accessed 11 August 2026.
- Alloy M4 Face Serum Rx — accessed 11 August 2026.
- Alloy M4 Body Treatment Rx — 0.2% estriol, $195, 3-month supply; accessed 11 August 2026.
- Alloy M4 12-week face-cream study report, Protocol DCS-102-23 — report dated 30 June 2024; accessed 11 August 2026.
- Alloy Terms of Use — effective 28 May 2026; accessed 10 August 2026.
Direct alternatives
- Midi Estriol+ Face Cream and Midi formula page — accessed 11 August 2026.
- Wisp Estriol Face Cream — accessed 11 August 2026.
- Musely Aging Repair Cream — accessed 11 August 2026.
- Winona Estriol Face Cream with Tretinoin and Winona states served — accessed 11 August 2026.
- Evernow Facial Estriol Cream — accessed 11 August 2026.
- QuickMD Estriol Face Cream — accessed 11 August 2026.
The HRT Index
- Affiliate Disclosure — current commissioned-provider list checked 11 August 2026.
- Find My HRT Path — approximately 90 seconds, no email, no account, and no stored health answers; checked 11 August 2026.
Regulatory and clinical
- FDA: Menopause — FDA statements on estriol and compounded “bioidentical” hormones; accessed 11 August 2026.
- FDA: Compounding and the FDA approval distinction — accessed 11 August 2026.
- DailyMed: Renova tretinoin cream 0.02% prescribing information — accessed 11 August 2026.
- DailyMed: Tretinoin cream USP (emollient) 0.05% prescribing information — accessed 11 August 2026.
- Draelos ZD. “A Double-Blind Randomized Pilot Study Evaluating the Safety and Efficacy of Topical MEP in the Facial Appearance Improvement of Estrogen Deficient Females.” Journal of Drugs in Dermatology. 2018;17(11):1186–1189. PMID: 30500138.
- Schmidt JB, et al. “Treatment of Skin Aging With Topical Estrogens.” International Journal of Dermatology. 1996;35(9):669–674. PMID: 8876303.
- Snyder A, et al. “Melasma Associated with Topical Estrogen Cream.” Journal of Clinical and Aesthetic Dermatology. 2017.